These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24681432)
1. Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas. Kuo CC; Lin CY; Shih YL; Hsieh CB; Lin PY; Guan SB; Hsieh MS; Lai HC; Chen CJ; Lin YW Clin Chem Lab Med; 2014 Aug; 52(8):1235-45. PubMed ID: 24681432 [TBL] [Abstract][Full Text] [Related]
2. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related]
3. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889 [TBL] [Abstract][Full Text] [Related]
4. Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinoma. Shih YL; Kuo CC; Yan MD; Lin YW; Hsieh CB; Hsieh TY Clin Epigenetics; 2016; 8():41. PubMed ID: 27110298 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357 [TBL] [Abstract][Full Text] [Related]
6. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma. Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036 [TBL] [Abstract][Full Text] [Related]
8. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction. Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805 [TBL] [Abstract][Full Text] [Related]
9. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma. Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717 [TBL] [Abstract][Full Text] [Related]
10. Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma. Lu CY; Lin KY; Tien MT; Wu CT; Uen YH; Tseng TL Genes Chromosomes Cancer; 2013 Jul; 52(7):636-43. PubMed ID: 23580407 [TBL] [Abstract][Full Text] [Related]
11. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma. Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma. Dong X; Hou Q; Chen Y; Wang X Dis Markers; 2017; 2017():2929381. PubMed ID: 28951629 [TBL] [Abstract][Full Text] [Related]
14. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma. Zhao R; Wang N; Huang H; Ma W; Yan Q Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. Shin SH; Kim BH; Jang JJ; Suh KS; Kang GH J Korean Med Sci; 2010 Aug; 25(8):1152-9. PubMed ID: 20676325 [TBL] [Abstract][Full Text] [Related]
16. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma. Qiu GH; Xie H; Wheelhouse N; Harrison D; Chen GG; Salto-Tellez M; Lai P; Ross JA; Hooi SC J Hepatol; 2007 Apr; 46(4):655-63. PubMed ID: 17258345 [TBL] [Abstract][Full Text] [Related]
18. HOXA9 promotes proliferation, metastasis and prevents apoptosis in hepatocellular carcinoma. Bao G; Wei H; Yan J; Li Y; Xue C; Fu R; Zhang M; Ding J; He H; Yu D; Yang F; Sun B J Cancer Res Clin Oncol; 2024 Sep; 150(9):422. PubMed ID: 39292289 [TBL] [Abstract][Full Text] [Related]
19. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma. Shih YL; Hsieh CB; Yan MD; Tsao CM; Hsieh TY; Liu CH; Lin YW J Gastroenterol Hepatol; 2013 Mar; 28(3):551-9. PubMed ID: 23215838 [TBL] [Abstract][Full Text] [Related]
20. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Wang J; Qin Y; Li B; Sun Z; Yang B Clin Biochem; 2006 Apr; 39(4):344-8. PubMed ID: 16527261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]